1. Home
  2. ORIC vs RDWR Comparison

ORIC vs RDWR Comparison

Compare ORIC & RDWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORIC
  • RDWR
  • Stock Information
  • Founded
  • ORIC 2014
  • RDWR 1996
  • Country
  • ORIC United States
  • RDWR Israel
  • Employees
  • ORIC N/A
  • RDWR N/A
  • Industry
  • ORIC Biotechnology: Pharmaceutical Preparations
  • RDWR EDP Services
  • Sector
  • ORIC Health Care
  • RDWR Technology
  • Exchange
  • ORIC Nasdaq
  • RDWR Nasdaq
  • Market Cap
  • ORIC 1.1B
  • RDWR 1.0B
  • IPO Year
  • ORIC 2020
  • RDWR 1999
  • Fundamental
  • Price
  • ORIC $12.20
  • RDWR $23.05
  • Analyst Decision
  • ORIC Strong Buy
  • RDWR Hold
  • Analyst Count
  • ORIC 8
  • RDWR 3
  • Target Price
  • ORIC $17.86
  • RDWR $32.50
  • AVG Volume (30 Days)
  • ORIC 1.1M
  • RDWR 216.4K
  • Earning Date
  • ORIC 11-13-2025
  • RDWR 10-29-2025
  • Dividend Yield
  • ORIC N/A
  • RDWR N/A
  • EPS Growth
  • ORIC N/A
  • RDWR N/A
  • EPS
  • ORIC N/A
  • RDWR 0.38
  • Revenue
  • ORIC N/A
  • RDWR $294,636,000.00
  • Revenue This Year
  • ORIC N/A
  • RDWR $11.39
  • Revenue Next Year
  • ORIC N/A
  • RDWR $7.43
  • P/E Ratio
  • ORIC N/A
  • RDWR $61.28
  • Revenue Growth
  • ORIC N/A
  • RDWR 10.40
  • 52 Week Low
  • ORIC $3.90
  • RDWR $18.46
  • 52 Week High
  • ORIC $14.93
  • RDWR $31.57
  • Technical
  • Relative Strength Index (RSI)
  • ORIC 46.07
  • RDWR 34.49
  • Support Level
  • ORIC $12.02
  • RDWR $22.38
  • Resistance Level
  • ORIC $13.04
  • RDWR $23.42
  • Average True Range (ATR)
  • ORIC 0.75
  • RDWR 0.96
  • MACD
  • ORIC -0.12
  • RDWR -0.19
  • Stochastic Oscillator
  • ORIC 20.69
  • RDWR 17.12

About ORIC Oric Pharmaceuticals Inc.

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

About RDWR Radware Ltd.

Radware Ltd provides cyber security and application delivery solutions. The company provides solutions for cloud, on-premises, and software-defined data centers (SDDC). The solutions of the company secure the digital experience by providing infrastructure, application, and network protection and availability services to enterprises globally. The business segments of the company are Radware's Core Business and The Hawks' Business. The company derives maximum revenue from Radware's Core Business. It generates the majority of its revenue from the United States.

Share on Social Networks: